SSRIs versus other antidepressants for depressive disorder.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD001851PMID 10796826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prevalence and treatment of depression in general practice

  2004cited by this paper
• North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care

  1999cited by this paper
• North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group.

  1999cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper
• Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

  1997cited by this paper
• A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.

  1997cited by this paper
• Are SSRIs a Cost-Effective Alternative to Tricyclics?

  1996cited by this paper
• A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.

  1996cited by this paper
• Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.

  1995cited by this paper
• Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

  1995cited by this paper
• Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.

  1995cited by this paper
• Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

  1995cited by this paper
• Moclobemide versus fluoxetine for a major depressive episode

  1995cited by this paper
• Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta‐analysis

  1995cited by this paper
• The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression

  1995cited by this paper
• Moclobemide versus fluoxetine in the treatment of inpatients with major depression.

  1995cited by this paper
• Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor: A Comparative Trial of Fluoxetine Versus Imipramine

  1994cited by this paper
• Controlled comparison of nefazodone and amitriptyline in major depressive inpatients

  1994cited by this paper
• What Price Depression?

  1994cited by this paper
• Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates

  1994cited by this paper
• A Multicenter Double‐Blind Trial of Paroxetine Versus Amitriptyline in Depressed Inpatients

  1994cited by this paper
• Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine

  1994cited by this paper
• Nefazodone and Imipramine in Major Depression: A Placebo-Controlled Trial

  1994cited by this paper
• Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study

  1994cited by this paper
• Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide

  1994cited by this paper
• A double‐blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes

  1994cited by this paper
• Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients

  1994cited by this paper
• COMPARISON OF FLUVOXAMINE AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS

  1994cited by this paper
• Moclobemide Versus Fluoxetine for Major Depressive Episodes

  1994cited by this paper
• A comparison of venlafaxine, trazodone, and placebo in major depression.

  1994cited by this paper
• Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.

  1994cited by this paper
• A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

  1994cited by this paper
• Benefits of new drugs are exaggerated

  1994cited by this paper
• Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression.

  1994cited by this paper
• A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

  1994cited by this paper
• A double‐blind, placebo‐controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice

  1994cited by this paper
• A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

  1994cited by this paper
• Controversies in Management: New or old antidepressants? New is better

  1994cited by this paper
• Fluoxetine and desipramine in major depressive disorder.

  1993cited by this paper
• A study comparing paroxetine placebo and imipramine in depressed patients.

  1993cited by this paper
• A double‐blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders

  1993cited by this paper
• Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

  1993cited by this paper
• Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.

  1993cited by this paper
• Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients

  1993cited by this paper
• A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

  1993cited by this paper
• [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].

  1993cited by this paper
• [Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient].

  1993cited by this paper
• FLUOXETINE VERSUS AMITRIPTYLINE IN THE TREATMENT OF DEPRESSIVE ILLNESS.

  1993cited by this paper
• Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial

  1993cited by this paper
• Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptyline

  1993cited by this paper
• Comparison of fluoxetine and desipramine in depressed outpatients

  1993cited by this paper
• A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

  1993cited by this paper
• A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients

  1993cited by this paper
• Paroxetine and imipramine: A 12-week, double-blind, multicentre study in hospitalized depressed patients

  1992cited by this paper
• [Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].

  1992cited by this paper
• Sleep and Paroxetine: A Comparison with Mianserin in Elderly Depressed Patients

  1992cited by this paper
• Paroxetine in the Treatment of Elderly Depressed Patients in General Practice: A Double‐Blind Comparison with Amitriptyline

  1992cited by this paper
• Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III)

  1992cited by this paper
• Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

  1992cited by this paper
• Double‐blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

  1991cited by this paper
• Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

  1991cited by this paper
• A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

  1991cited by this paper
• Fluoxetine versus trazodone: efficacy and activating-sedating effects.

  1991cited by this paper
• A comparison of fluoxetine and amitriptyline in the treatment of major depression.

  1991cited by this paper
• Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

  1991cited by this paper
• The efficacy of fluoxetine versus maprotiline in depressed patients and by dose

  1991cited by this paper
• Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.

  1991cited by this paper
• A Double‐blind Parallel Study Comparing Fluoxetine with Imipramine in the Treatment of Atypical Depression

  1991cited by this paper
• Selektive Re-uptake-Hemmung und ihre Bedeutung für die Depression

  1991cited by this paper
• A DOUBLE‐BUND, RANDOMISED COMPARISON OF FLUVOXAMINE WITH DOTHIEPIN IN THE TREATMENT OF DEPRESSION IN ELDERLY PATIENTS

  1991cited by this paper
• Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.

  1991cited by this paper
• The efficacy and safety of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study

  1991cited by this paper
• Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of Depression

  1991cited by this paper
• [Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners].

  1991cited by this paper
• A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

  1991cited by this paper
• A general parametric approach to the meta-analysis of randomized clinical trials.

  1991cited by this paper
• Fluoxetine in Major Depression: Efficacy, Safety and Effects on Sleep Polygraphic Variables

  1990cited by this paper
• Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.

  1990cited by this paper
• A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness.

  1990cited by this paper
• Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.

  1990cited by this paper
• Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.

  1990cited by this paper
• A placebo- and imipramine-controlled study of paroxetine.

  1990cited by this paper
• Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.

  1990cited by this paper
• Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.

  1990cited by this paper
• A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.

  1990cited by this paper
• The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.

  1990cited by this paper
• A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.

  1990cited by this paper
• A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.

  1990cited by this paper
• Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder.

  1989cited by this paper
• The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.

  1989cited by this paper
• A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice.

  1989cited by this paper
• A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.

  1989cited by this paper
• Fluoxetine Versus Trazodone in Depressed Geriatric Patients

  1989cited by this paper
• A double‐blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

  1989cited by this paper
• Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.

  1989cited by this paper
• Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.

  1989cited by this paper
• Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.

  1989cited by this paper
• A double‐blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

  1989cited by this paper
• A comparative trial of fluoxetine versus trazodone in outpatients with major depression.

  1989cited by this paper
• The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double‐blind comDarison with amitriptyline in I depressed outpatients

  1989cited by this paper

• Molecular pathways linking the serotonin transporters (SERT) to depressive disorder: from mechanisms to treatments.

  2025cites this paper
• Prescription patterns in unipolar depression: A nationwide Danish register‐based study of 113,175 individuals followed for 10 years

  2023cites this paper
• Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis

  2022cites this paper
• A Revision on the Effectiveness of Omega-3 Polyunsaturated Fatty Acids as Monotherapy in the Treatment of Major Depressive Disorder

  2022cites this paper
• CONSUMO DE FÁRMACOS PSICOTRÓPICOS EM UMA FARMÁCIA BÁSICA DE CONGONHAS, MINAS GERAIS, BRASIL

  2019cites this paper
• Pharmacological & Toxicological Evaluation of Nelumbo Nucifera Fruit

  2019cites this paper
• Prescription Pattern of Antidepressants in Korea for Major Neurological Disorders: Before the Policy Change in 2017

  2019cites this paper
• EXPLAINING DEPRESSION: A DISCOURSE ANALYSIS OF FAMILY PHYSICIANS’ AND NEUROSCIENTISTS’ ACCOUNTS OF EXPLANATORY MODELS AND THE CHEMICAL IMBALANCE HYPOTHESIS OF DEPRESSION

  2019cites this paper
• A randomized controlled double-blind clinical trial comparing versus placebo the effect of an edible algal extract (Ulva Lactuca) on the component of depression in healthy volunteers with anhedonia

  2018cites this paper
• Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms

  2017cites this paper
• Childhood Abuse History in Depression Predicts Better Response to Antidepressants with Higher Serotonin Transporter Affinity: A Pilot Investigation

  2017cites this paper
• Antidepressants for irritable bowel syndrome—A systematic review

  2017cites this paper
• Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression

  2015influential citation
• Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data: A Possible Proxy for Medical Prescription Behavior?

  2015cites this paper
• Psychiatric Disturbances of Attention

  2014cites this paper
• Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition

  2014cites this paper
• Selective Serotonin Reuptake Inhibitors for Mild Cognitive Impairment : A Systematic Review

  2014cites this paper
• Paroxetine versus other anti-depressive agents for depression.

  2014cites this paper
• Prescribing for personality disorder: qualitative study of interviews with general and forensic consultant psychiatrists

  2014cites this paper
• The failure of the antidepressant drug discovery process is systemic

  2013cites this paper
• Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (II) : Antidepressant Efficacy Compared with Placebo, Difference in Efficacy of Antidepressants, and Appropriate Time of Efficacy Judgment in Antidepressant Therapy

  2013cites this paper
• The duty to be Well-informed: The case of depression

  2013cites this paper
• The role of the serotonergic system at the interface of aggression and suicide.

  2013cites this paper
• Fluoxetine versus other types of pharmacotherapy for depression.

  2013cites this paper
• Manufacturing Madness : The Pseudoscience of Modern Psychiatry Part 1

  2013cites this paper
• Chapter 33 – What Treatments Are Effective for Depression in the Palliative Care Setting?

  2013cites this paper
• Correlation study of SSRIs drugs in Sexual Dysfunction

  2013cites this paper
• Clinical and Demographic Predictors of Improvement during Duloxetine Treatment in Patients with Major Depression

  2011cites this paper
• A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.

  2011cites this paper
• Omega-3 Fatty Acids for the Treatment of Depression: Systematic Review and Meta-Analysis

  2011influential citation
• Solving the antidepressant efficacy question: effect sizes in major depressive disorder.

  2011cites this paper
• Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis.

  2011cites this paper
• Improving the clinical effectiveness of antidepressant treatment.

  2011cites this paper
• Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets.

  2011cites this paper
• Factors associated to antidepressant prescription for civil servants of Belo Horizonte, MG

  2010cites this paper
• Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations

  2010cites this paper
• Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

  2010cites this paper
• PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

  2010cites this paper
• An algorithm for the pharmacological treatment of depression

  2010cites this paper
• Fluvoxamine versus other anti-depressive agents for depression.

  2010cites this paper
• Pharmacogenetics of SSRIs and Sexual Dysfunction

  2010cites this paper
• Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

  2009cites this paper
• Emerging drugs for major depressive disorder

  2009cites this paper
• Revisão das diretrizes da Associação Médica Brasileira para o tratamento da depressão (Versão integral)

  2009cites this paper
• An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.

  2009cites this paper
• Major Depression and Metabolic Encephalopathy: Syndromes More Alike Than Not?

  2009cites this paper
• [Guidelines of the Brazilian Medical Association for the treatment of depression (complete version)].

  2009cites this paper
• Recent advances in the biological treatment of mood disorders

  2009cites this paper
• [Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Complete version)].

  2009cites this paper
• Escitalopram versus other antidepressive agents for depression.

  2009cites this paper
• Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

  2009cites this paper
• Review of the guidelines of the Brazilian Medical Association for the treatment of depression ( Full version )

  2009cites this paper
• Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders

  2009cites this paper
• Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

  2009cites this paper
• Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis

  2009cites this paper
• EFEITO DO EXERCÍCIO FÍSICO AERÓBICO NOS SINTOMAS DEPRESSIVOS EM PACIENTES COM DEPRESSÃO SEVERA APÓS UM ANO DO TÉRMINO DA INTERVENÇÃO

  2009cites this paper
• Co-prescription of antidepressants with other psychotropics: Distinct profile of escitalopram

  2008cites this paper
• Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with Other Antidepressants

  2008cites this paper
• Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.

  2008cites this paper
• The serotonin transporter gene and effectiveness of SSRIs

  2008cites this paper
• Serotonin Dysfunction in Autism

  2008cites this paper
• Stepped care treatment of postpartum depression: a primary care-based management model.

  2008cites this paper
• Cost‐efficient treatment for uninsured or underinsured patients with hypertension, depression, diabetes mellitus, insomnia, and gastroesophageal reflux

  2008cites this paper
• Not Obsolete: Continuing Roles for TCAs and MAOIs

  2007cites this paper
• Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

  2007cites this paper
• Clinical Evidence Review : Best Practice Diagnosis and Treatment of Major Depression 2007

  2007cites this paper
• Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan 1

  2007cites this paper
• [Depressive disorders. A diagnostic and therapeutic challenge also for primary care].

  2007cites this paper
• Antidepressants in child and adolescent depression: where are the bugs?

  2007cites this paper
• Diagnosis and treatment of major depression 2007.

  2007cites this paper
• Predictors of Self-Reported Antidepressant Adherence

  2007cites this paper
• Venlafaxine versus other anti-depressive agents for depression.

  2007cites this paper
• FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.

  2007cites this paper
• Paroxetine versus other anti-depressive agents for depression.

  2007cites this paper
• Depressionsbehandlung in Deutschland

  2007cites this paper
• Diagnosis and Treatment of Major Depression 2007

  2007cites this paper
• Milnacipran versus other antidepressive agents for depression.

  2007cites this paper
• Antidepressant Utilization in British Columbia From 1996 to 2004: Increasing Prevalence but Not Incidence

  2007cites this paper
• Burden of phase-specific sexual dysfunction with SSRIs.

  2006cites this paper
• Test Your Knowledge: Ten Questions on Depression in Adults

  2006cites this paper
• El futuro de la farmacoterapia antidepresiva

  2006cites this paper
• Lithium versus antidepressants in the long-term treatment of unipolar affective disorder.

  2006cites this paper
• WFSBP Guidelines for Biological Treatment of Bipolar Disorders Part I - Treatment of Bipolar Depression

  2006cites this paper
• Augmentation of the neurochemical and behavioural effects of SSRIs

  2006cites this paper
• Mortality and work-related disability as long-term consequences of anxiety and depression: historical cohort designs based on the HUNT-2 study

  2006cites this paper
• Research report Burden of phase-specific sexual dysfunction with SSRIs B

  2006cites this paper
• An evidence-based approach to the management of depression.

  2006cites this paper
• Adaptive plasticity during stress and depression and the role of glutamate-nitric oxide pathways

  2006cites this paper
• The patient with excessive worry

  2006cites this paper
• The Dodo manifesto

  2005cites this paper
• The medical management of depression.

  2005cites this paper
• Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder

  2005cites this paper
• Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature

  2005cites this paper
• What to Know First: Thinking About Depression

  2005cites this paper
• Cost-Effectiveness of Mental Health Interventions in Estonia

  2005cites this paper
• Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

  2005cites this paper
• The assessment of serotonin function in major depression.

  2005cites this paper
• trialsreview of randomised controlled selective serotonin reuptake inhibitors: Association between suicide attempts and

  2005cites this paper
• Was tun bei Depressionen?

  2005cites this paper
• Aspects of the relationship between doctors and depressed patients that enhance satisfaction with primary care.

  2005cites this paper